COVID-19 | DCGI Approves Clinical Trial On Mixing Covishield & Covaxin In India Post-ICMR’s Findings
In a development that can have a huge impact on India’s vaccination drive, the Drugs Controller General of India has given its go-ahead to a study on mixing Covishield and Covaxin. This comes days after the ICMR observed in a preprint study that a combination of these COVID-19 vaccines elicited better safety and immunogenicity results than two doses of the same vaccine. However, its research was limited to a comparison of 18 persons in Uttar Pradesh who had been accidentally administered the two different vaccines with 40 persons inoculated with Covishield and Covaxin each.
.
.
- 12 Aug 2021
- WerIndia
Loading ...
